Skip to main content
Future Journal of Pharmaceutical Sciences

Table 5 Method precision

From: A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form

Sample preparations

% assay

Lamivudine

Dolutegravir

Sample-1

99.7

99.6

Sample-2

100.1

100.1

Sample-3

99.6

99.7

Sample-4

100.8

99.2

Sample-5

99.5

100.4

Sample-6

100.3

100.0

Average

100.0

99.8

S.D

0.50

0.42

%RSD

0.5

0.4

Back to article page